new independent thermobalancing treatment with therapeutic device for chronic prostatitis/chronic pelvic pain syndrome

Background: medications, alternative and complementary treatments for type-iii chronic prostatitis/chronic pelvic pain syndrome (cp/cpps) are used frequently. the aim of this article is to define thermobalancing therapy as an independent treatment for internal diseases, such as cp/cpps. methods: the effect of thermobalancing therapy (tt) by using dr. allen’s therapeutic device-(datd) on patients with cp/cpps was investigated. national institute of health chronic prostatitissymptomindex (nih-cpsi) scores, prostaticvolume(pv),andmaximum urinaryflowrate (qmax) weremeasuredinonegroup of 45 patientswhounderwentttanda control group that did nothave tt. these all parameters were compared between groups. results: no significant difference was found at baseline evaluation in treatment and control groups with regard to age, nih-cpsi score, pv orqmax. in the treatment group pain score decreased and quality of life (qol) improved significantly, whereas in the control group no changes. tt reduced pv and increasedqmax significantly, whereas in the control group tt did not elicit significant changes in pv and qmax. conclusions: the study has explored that tt with datd as monotherapy for cp/cpps patients: (i) reduces pain dramatically and improves qol; (ii) reduces pv and increasesqmax. none of the patients who received tt suffered side effects and the cost of tt compares favourably with the cost of conventional treatment. thus, tt could be recommended as a new independent treatment for cp/cpps.